Agenus (AGEN) Net Income (QoQ) (2010 - 2026)
Agenus (AGEN) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Agenus | 229.92 Mn | 194.93 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.05% |
| Dec 31, 2025 | 76.32% |
| Sep 30, 2025 | 76.80% |
| Jun 30, 2025 | -14.30% |
| Mar 31, 2025 | 44.07% |
| Dec 31, 2024 | 31.12% |
| Sep 30, 2024 | -9.24% |
| Jun 30, 2024 | 1.08% |
| Mar 31, 2024 | -1,205.69% |
| Dec 31, 2023 | 89.65% |
| Sep 30, 2023 | 15.12% |
| Jun 30, 2023 | 0.19% |
| Mar 31, 2023 | 4.96% |
| Dec 31, 2022 | -37.42% |
| Sep 30, 2022 | 6.47% |
| Jun 30, 2022 | -23.20% |
| Mar 31, 2022 | 33.67% |
| Dec 31, 2021 | -141.48% |
| Sep 30, 2021 | 202.42% |
| Jun 30, 2021 | -192.53% |